| Jan'20 | Jan'19 | Jan'18 | Jan'17 | Jan'16 | Jan'15 | Jan'14 | Jan'13 | Jan'12 | Jan'11 | Jan'10 | Jan'09 | Jan'08 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating activities | ||||||||||||
Net income (loss) | ||||||||||||
214,500 | -80,800 | -566,900 | -582,100 | -330,500 | 81,800 | 228,800 | 247,400 | 285,300 | 212,000 | 58,000 | 183,600 | 356,200 |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||||||
Charge for acquired in-process research and development | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 26,900 | 5,500 |
Depreciation, amortization, and accretion | ||||||||||||
127,300 | 95,200 | 108,400 | 139,200 | 145,800 | 145,900 | 128,900 | 127,800 | 115,500 | 105,400 | 111,500 | 91,800 | 61,300 |
Stock-based compensation expense | ||||||||||||
362,400 | 249,500 | 261,400 | 221,800 | 197,200 | 165,600 | 132,200 | 156,300 | 108,800 | 80,700 | 93,600 | 89,500 | 99,300 |
Deferred income taxes | ||||||||||||
-10,300 | 6,800 | 39,100 | 38,800 | -235,900 | 18,800 | 49,400 | 28,300 | 33,800 | 2,100 | 13,500 | 13,800 | -56,500 |
Excess tax benefits from stock-based compensation | ||||||||||||
- | - | - | - | - | - | 9,100 | 12,900 | 31,500 | 0 | 0 | - | - |
Impairment of goodwill | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 21,000 | 128,900 | 0 |
Restructuring and other exit costs, net | ||||||||||||
500 | 31,700 | 94,100 | 80,500 | 0 | 3,100 | 12,800 | 43,900 | -1,300 | 10,800 | 48,200 | 38,900 | 0 |
Other operating activities | ||||||||||||
-11,900 | 2,200 | 7,300 | -7,700 | -25,000 | 16,200 | -16,100 | 6,700 | -300 | -2,000 | - | - | - |
Changes in operating assets and liabilities, net of business combinations: | ||||||||||||
Accounts receivable | ||||||||||||
178,500 | 25,400 | -13,300 | -201,500 | 195,500 | 17,300 | -72,300 | 98,100 | 71,800 | 40,700 | -37,300 | -81,800 | 78,300 |
Prepaid expenses and other current assets | ||||||||||||
-58,500 | -7,500 | 9,900 | 13,500 | 2,800 | -6,800 | 20,300 | -100 | -17,700 | 12,900 | -4,400 | 7,800 | 13,600 |
Accounts payable and accrued liabilities | ||||||||||||
-90,800 | -58,500 | -13,900 | 2,700 | 24,900 | 130,800 | -19,600 | -28,300 | 2,900 | 85,700 | -80,300 | -93,600 | 81,400 |
Deferred revenue | ||||||||||||
916,700 | 197,000 | 168,300 | 267,000 | 360,500 | 245,200 | 66,000 | 113,300 | 129,600 | 71,500 | -34,000 | 40,800 | 125,600 |
Accrued income taxes | ||||||||||||
6,100 | -34,500 | -22,100 | -100,900 | 3,500 | -50,700 | 37,000 | 31,200 | 52,400 | 32,400 | 600 | 26,900 | 14,600 |
Net cash provided by operating activities | ||||||||||||
1,415,100 | 377,100 | 900 | 169,700 | 414,000 | 708,600 | 563,500 | 559,100 | 573,500 | 540,800 | 246,800 | 593,900 | 708,500 |
Investing activities | ||||||||||||
Purchases of marketable securities | ||||||||||||
19,900 | 138,200 | 514,000 | 1,867,900 | 2,250,100 | 1,355,100 | 1,214,200 | 1,397,700 | 614,200 | 507,200 | 568,900 | 118,600 | 727,000 |
Sales of marketable securities | ||||||||||||
22,400 | 319,600 | 489,000 | 1,257,700 | 329,400 | 190,000 | 537,000 | 332,900 | 149,500 | 135,300 | 26,400 | 75,000 | 799,100 |
Maturities of marketable securities | ||||||||||||
5,000 | 211,400 | 594,300 | 1,057,200 | 1,376,600 | 969,000 | 742,100 | 764,800 | 409,600 | 275,400 | 328,700 | 8,400 | 0 |
Capital expenditures | ||||||||||||
53,200 | 67,000 | 50,700 | 76,000 | 72,400 | 75,500 | 64,200 | 56,400 | 63,000 | 28,300 | 31,700 | 78,400 | 43,300 |
Acquisitions, net of cash acquired | ||||||||||||
0 | 1,040,200 | 0 | 85,200 | 148,500 | 630,000 | 176,100 | 263,700 | 221,700 | 13,500 | 26,100 | 364,500 | 114,500 |
Other investing activities | ||||||||||||
11,600 | -4,000 | 12,200 | 13,800 | 44,500 | 4,000 | 18,600 | 27,100 | 30,500 | 4,000 | 11,400 | - | 0 |
Net cash (used in) provided by investing activities | ||||||||||||
-57,300 | -710,400 | 506,400 | 272,000 | -809,500 | -905,600 | -194,000 | -647,200 | -370,300 | -142,300 | -283,000 | -478,100 | -85,700 |
Financing activities | ||||||||||||
Proceeds from issuance of common stock | ||||||||||||
93,700 | 90,900 | 94,400 | 119,600 | 110,800 | 175,400 | 312,800 | 220,200 | 176,100 | 120,900 | 70,000 | 90,100 | 187,300 |
Taxes paid related to net share settlement of equity awards | ||||||||||||
112,500 | 143,400 | 143,100 | 76,200 | 51,600 | 40,000 | 24,600 | - | - | - | - | - | - |
Repurchase and retirement of common shares | ||||||||||||
442,500 | 293,500 | 699,000 | 621,700 | 458,000 | 372,400 | 423,800 | 431,200 | 327,400 | 280,300 | 63,200 | 256,600 | 563,000 |
Draws on line of credit | ||||||||||||
- | - | - | - | - | - | - | 110,000 | 0 | 0 | 2,200 | 912,400 | 0 |
Proceeds from debt, net of discount | ||||||||||||
498,900 | 500,000 | 496,900 | 0 | 748,300 | 0 | 0 | 745,600 | 0 | 0 | - | - | - |
Repayments of debt | ||||||||||||
500,000 | 0 | 400,000 | 0 | 0 | - | - | 110,000 | 0 | 0 | 54,300 | 860,300 | 0 |
Excess tax benefits from stock-based compensation | ||||||||||||
- | - | - | - | - | - | 9,100 | 12,900 | 31,500 | 0 | 0 | - | - |
Other financing activities | ||||||||||||
-4,400 | -2,100 | -5,800 | 0 | -6,300 | -3,400 | 0 | -6,100 | 0 | 0 | - | - | - |
Net cash (used in) provided by financing activities | ||||||||||||
-466,800 | 151,900 | -656,600 | -578,300 | 343,200 | -240,400 | -126,500 | 541,400 | -119,800 | -159,400 | -45,300 | -114,400 | -375,700 |
Effect of exchange rate changes on cash and cash equivalents | ||||||||||||
-2,300 | -10,600 | 14,200 | -3,300 | -5,300 | -5,000 | -2,200 | 2,000 | -1,600 | -2,700 | 2,600 | -1,700 | 4,900 |
Net increase (decrease) in cash and cash equivalents | ||||||||||||
888,700 | -192,000 | -135,100 | -139,900 | -57,600 | -442,400 | 240,800 | 455,300 | 81,800 | 236,400 | -78,900 | -300 | 252,000 |
Supplemental cash flow information: | ||||||||||||
Cash paid during the year for interest | ||||||||||||
67,800 | 59,000 | 54,600 | 47,600 | 34,700 | 20,400 | 20,500 | 400 | 0 | 0 | - | - | - |
Cash paid for income taxes, net of tax refunds | ||||||||||||
60,300 | 78,000 | 84,500 | 77,700 | 59,100 | 63,400 | 75,700 | 59,700 | 63,000 | 32,500 | 42,100 | 63,400 | 47,100 |
Non-cash investing and financing activities: | ||||||||||||
Fair value of common stock issued to settle liability-classified restricted stock units | ||||||||||||
23,500 | 0 | 0 | - | - | - | - | - | - | - | - | - | - |
Fair value of equity awards assumed | ||||||||||||
0 | 10,300 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Fair value of common stock issued as consideration for business combination | ||||||||||||
0 | 44,800 | 0 | 0 | - | - | - | - | - | - | - | - | - |
Increase in goodwill and corresponding change in other accrued liabilities resulting from adjustments to purchase accounting estimates | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 2,800 | 6,400 |